Drugs / r-ATG
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02766465 Background | Mar 2017 → May 2023 | sickle cell disease | Medical College of Wisconsin | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | r-ATG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02766465 ↗ |
| Route | Intravenous | “r-ATG will be administered IV” NCT02766465 ↗ |